Literature DB >> 27155222

Pias1 is essential for erythroid and vascular development in the mouse embryo.

Jerfiz D Constanzo1, Mi Deng2, Smita Rindhe1, Ke-Jing Tang3, Cheng-Cheng Zhang2, Pier Paolo Scaglioni4.   

Abstract

The protein inhibitor of activated STAT-1 (PIAS1) is one of the few known SUMO E3 ligases. PIAS1 has been implicated in several biological processes including repression of innate immunity and DNA repair. However, PIAS1 function during development and tissue differentiation has not been studied. Here, we report that Pias1 is required for proper embryonic development. Approximately 90% of Pias1 null embryos die in utero between E10.5 and E12.5. We found significant apoptosis within the yolk sac (YS) blood vessels and concomitant loss of red blood cells (RBCs) resulting in profound anemia. In addition, Pias1 loss impairs YS angiogenesis and results in defective capillary plexus formation and blood vessel occlusions. Moreover, heart development is impaired as a result of loss of myocardium muscle mass. Accordingly, we found that Pias1 expression in primary myoblasts enhances the induction of cardiac muscle genes MyoD, Myogenin and Myomaker. PIAS1 protein regulation of cardiac gene transcription is dependent on transcription factors Myocardin and Gata-4. Finally, endothelial cell specific inactivation of Pias1 in vivo impairs YS erythrogenesis, angiogenesis and recapitulates loss of myocardium muscle mass. However, these defects are not sufficient to recapitulate the lethal phenotype of Pias1 null embryos. These findings highlight Pias1 as an essential gene for YS erythropoiesis and vasculogenesis in vivo.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Embryonic development; Fetal erythropoiesis; Pias1; Yolk sac capillary plexus

Mesh:

Substances:

Year:  2016        PMID: 27155222      PMCID: PMC4906794          DOI: 10.1016/j.ydbio.2016.04.013

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  52 in total

1.  The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

Authors:  Andrea Rabellino; Brandon Carter; Georgia Konstantinidou; Shwu-Yuan Wu; Alessandro Rimessi; Lauren A Byers; John V Heymach; Luc Girard; Cheng-Ming Chiang; Julie Teruya-Feldstein; Pier Paolo Scaglioni
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

2.  The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells.

Authors:  Yuefeng Tang; Anne Harrington; Xuehui Yang; Robert E Friesel; Lucy Liaw
Journal:  Genesis       Date:  2010-09       Impact factor: 2.487

Review 3.  PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.

Authors:  J J Palvimo
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

Review 4.  Molecular control of myogenesis: antagonism between growth and differentiation.

Authors:  E N Olson; T J Brennan; T Chakraborty; T C Cheng; P Cserjesi; D Edmondson; G James; L Li
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

5.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

6.  PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

Authors:  Bin Liu; Sheldon Mink; Kelly A Wong; Natalie Stein; Crescent Getman; Paul W Dempsey; Hong Wu; Ke Shuai
Journal:  Nat Immunol       Date:  2004-08-15       Impact factor: 25.606

7.  Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions.

Authors:  Igor E Konstantinov; John G Coles; Cathy Boscarino; Mark Takahashi; Jason Goncalves; Julia Ritter; Glen S Van Arsdell
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

8.  Controlling hematopoiesis through sumoylation-dependent regulation of a GATA factor.

Authors:  Hsiang-Ying Lee; Kirby D Johnson; Tohru Fujiwara; Meghan E Boyer; Shin-Il Kim; Emery H Bresnick
Journal:  Mol Cell       Date:  2009-12-25       Impact factor: 17.970

9.  Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.

Authors:  Yaron Galanty; Rimma Belotserkovskaya; Julia Coates; Sophie Polo; Kyle M Miller; Stephen P Jackson
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

10.  Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.

Authors:  Christopher M Sturgeon; Andrea Ditadi; Geneve Awong; Marion Kennedy; Gordon Keller
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

View more
  6 in total

1.  The significance of SUMOylation of angiogenic factors in cancer progression.

Authors:  Mei Wang; Xiaodong Jiang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

Review 2.  The Role of PIAS SUMO E3-Ligases in Cancer.

Authors:  Andrea Rabellino; Cristina Andreani; Pier Paolo Scaglioni
Journal:  Cancer Res       Date:  2017-03-22       Impact factor: 12.701

Review 3.  Sumoylation in Physiology, Pathology and Therapy.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

Review 4.  The role of SUMOylation during development.

Authors:  Ana Talamillo; Orhi Barroso-Gomila; Immacolata Giordano; Leiore Ajuria; Marco Grillo; Ugo Mayor; Rosa Barrio
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

Review 5.  SUMOylation in development and neurodegeneration.

Authors:  Tak-Yu Yau; Oscar Molina; Albert J Courey
Journal:  Development       Date:  2020-03-18       Impact factor: 6.862

6.  Age-Dependent and -Independent Effects of Perivascular Adipose Tissue and Its Paracrine Activities during Neointima Formation.

Authors:  Eva Schütz; Rajinikanth Gogiraju; Maria Pavlaki; Ioannis Drosos; George S Georgiadis; Christos Argyriou; Amina Rim Ben Hallou; Fotios Konstantinou; Dimitrios Mikroulis; Rebecca Schüler; Magdalena L Bochenek; Sogol Gachkar; Katja Buschmann; Mareike Lankeit; Susanne H Karbach; Thomas Münzel; Dimitrios Tziakas; Stavros Konstantinides; Katrin Schäfer
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.